Daniel K Burns

Daniel K Burns

UNVERIFIED PROFILE

Are you Daniel K Burns?   Register this Author

Register author
Daniel K Burns

Daniel K Burns

Publications by authors named "Daniel K Burns"

Are you Daniel K Burns?   Register this Author

25Publications

662Reads

22Profile Views

Neuropathologic features of TOMM40 '523 variant on late-life cognitive decline.

Alzheimers Dement 2017 Dec 15;13(12):1380-1388. Epub 2017 Jun 15.

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA; Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jalz.2017.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723540PMC
December 2017

'523 variant and cognitive decline in older persons with ε3/3 genotype.

Neurology 2017 Feb 20;88(7):661-668. Epub 2017 Jan 20.

From the Rush Alzheimer's Disease Center (L.Y., R.S.W., C.G., L.L.B., D.A.B.) and Department of Neurological Sciences (L.Y., R.S.W., C.G., L.L.B., D.A.B.), Rush University Medical Center, Chicago, IL; Department of Neurology (M.W.L., A.D.R., A.M.S.), Duke University School of Medicine, Durham; Zinfandel Pharmaceuticals, Inc (D.K.B., A.D.R.), Research Triangle Park, NC; Program in Translational NeuroPsychiatric Genomics (P.L.D.), Institute for the Neurosciences, Departments of Neurology and Psychiatry, Brigham and Women's Hospital; Harvard Medical School (P.L.D.), Boston; and Program in Medical and Population Genetics (P.L.D.), Broad Institute, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317377PMC
February 2017

The SSV Evaluation System: A Tool to Prioritize Short Structural Variants for Studies of Possible Regulatory and Causal Variants.

Hum Mutat 2016 09 27;37(9):877-83. Epub 2016 Jun 27.

Department of Neurology, Duke University Medical Center, Durham, North Carolina, 27710.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.23023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983215PMC
September 2016

New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.

Curr Neurol Neurosci Rep 2016 May;16(5):48

Joseph and Kathleen Bryan Alzheimer's Disease Center, Department of Neurology, Duke University Medical Center, 2200 W Main Street, Suite A200, Durham, NC, 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-016-0643-8DOI Listing
May 2016

A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease.

Alzheimers Dement (N Y) 2016 Jan;2(1):30-44

Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, North Carolina; Department of Neurology, Duke University Medical Center, Durham, North Carolina; Cabernet Pharmaceuticals, Durham, North Carolina; Zinfandel Pharmaceuticals, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trci.2015.12.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817110PMC
January 2016

The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

J Parkinsons Dis Alzheimers Dis 2014 Nov;1(1)

Department of Neurology, Duke University Medical Center, Durham, NC 27710, USA ; Joseph and Kathleen Bryan Alzheimer's Disease Research Center, Department of Neurology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.13188/2376-922X.1000003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346331PMC
November 2014

Designing pharmacogenomic studies to be fit for purpose.

Pharmacogenomics 2010 Dec;11(12):1657-67

Deane Drug Discovery Institute, Duke University, Durham, NC 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.10.140DOI Listing
December 2010

Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.

Curr Pharm Des 2009 ;15(32):3754-63

Cabernet Pharmaceuticals, One Science Drive, Box 90344, Durham NC 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161209789649538DOI Listing
January 2010

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example.

Pharmacogenomics 2009 Feb;10(2):225-33

GlaxoSmithKline Genetics, 5 Moore Drive, PO Box 13398, Research Triangle Park, NC 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.10.2.225DOI Listing
February 2009

Disease-specific target selection: a critical first step down the right road.

Drug Discov Today 2005 Feb;10(3):177-89

GlaxoSmithKline R&D, Research Triangle Park, NC 27709, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1359-6446(04)03321-5DOI Listing
February 2005

A single-nucleotide polymorphism tagging set for human drug metabolism and transport.

Nat Genet 2005 Jan 19;37(1):84-9. Epub 2004 Dec 19.

Department of Biology (Galton Lab), University College London, The Darwin Building, Gower Street, London WC1E 6BT, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ng1488
Publisher Site
http://dx.doi.org/10.1038/ng1488DOI Listing
January 2005